Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium citrate
Drug ID BADD_D02522
Description Not Available
Indications and Usage Lithium is used as a mood stabilizer, and is used for treatment of depression and mania. It is often used in bipolar disorder treatment.
Marketing Status Not Available
ATC Code N05AN01
DrugBank ID DB14507
KEGG ID D04749
MeSH ID C070669
PubChem ID 13520
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms lithium citrate | Litarex | monolithium citrate
Chemical Information
Molecular Formula C6H5Li3O7
CAS Registry Number 919-16-4
SMILES [Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperadrenalism24.08.04.003; 14.11.01.028; 05.01.01.005-Not Available
Impulsive behaviour19.18.01.001-Not Available
Maternal drugs affecting foetus18.03.03.009; 12.03.03.006-Not Available
Multiple cardiac defects02.08.02.006; 03.07.06.002-Not Available
Myocardial fibrosis02.04.02.016-Not Available
Neonatal respiratory distress syndrome22.11.02.010; 18.04.10.003-Not Available
Overweight14.03.02.021-Not Available
Persecutory delusion19.10.01.007-Not Available
Cardiomyopathy acute02.04.01.008-Not Available
Kidney enlargement20.01.06.003-Not Available
Live birth18.08.02.007-Not Available
Renal oncocytoma20.01.04.019; 16.27.01.008-Not Available
Sopor19.02.04.002; 17.02.04.021-Not Available
Antipsychotic drug level above therapeutic13.17.01.027-Not Available
Antipsychotic drug level increased13.17.01.030-Not Available
Multiple system atrophy24.06.03.013; 17.02.10.023-Not Available
Stress cardiomyopathy24.04.04.026; 02.04.01.012-Not Available
Antipsychotic drug level decreased13.17.01.029-Not Available
Skeletal dysplasia15.11.01.007; 03.11.01.007-Not Available
Clear cell renal cell carcinoma20.01.04.008; 16.08.02.004-Not Available
Hyperosmolar hyperglycaemic state17.02.04.020; 14.07.04.006; 05.07.04.006-Not Available
Kidney angiomyolipoma20.01.04.009; 16.27.01.004-Not Available
End stage renal disease20.01.03.019-Not Available
The 10th Page    First    Pre   10    Total 10 Pages